Anteris Technologies Ltd Annual Shareholders Meeting Transcript
So good morning, everybody. Thank you for attending this morning. I'm obviously super excited to be back in Australia and Sydney as always on a lovely day. As John pointed out there, we're at the sharp end of this thing now. And what I want to talk to you today about is the very deliberate nature of how this product moves from here, through the FDA and into market. Because I get a lot of questions, more comments about what we can and can't do as a small company, from folks who maybe don't necessarily know what we can and can't do as a small company.
So today I'm going to walk through obviously the financial results from last year, but also give you a view as to what's coming this year, particularly around the FDA and those things. I'm going to start with a little video. We've compressed about four years into four minutes here. And the reason I did that is to show how this product came about, that it's not a random event. The fact that it's clinically superior and market leading is not a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |